Bimatoprost/Timolol Versus Travoprost/Timolol

Kasr El Aini Hospital

Status: Completed

Conditions: Glaucoma

Treatments: Drug: Duotrav; Drug: Ganfort

Study type: Interventional

Funder types: Other

Identifiers

NCT01542710

GANDUO-2011 (Other Identifier)

GFDU-2011

Fixed Glaucoma Medications

Details and patient eligibility

About

The purpose of this study is to compare 2 fixed combination medications in intraocular pressure lowering.

Full description

PURPOSE: To compare the efficacy of bimatoprost/timolol (BTFC) or travoprost/timolol (TTFC) fixed combinations on intraocular pressure (IOP) reduction in an Egyptian population.

METHODS: Patients with primary open angle glaucoma (POAG) were randomized to receive either BTFC or TTFC. IOPs were measured at baseline, 2 weeks, and 1, 2, 4, and 6 months. The primary outcome measures were the mean change in IOP from baseline

Enrollment: 80 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Glaucoma

Exclusion criteria

• No other ocular diseases

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

80 participants in 1 patient group

Glaucoma fixed Combination Medications

Experimental group

Treatment:

Drug: Duotrav

Drug: Ganfort